VCS
Vaughan & Co Securities’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $654K | Sell |
3,525
-6
| -0.2% | -$1.11K | 0.38% | 31 |
|
|
2025
Q1 | $740K | Sell |
3,531
-57
| -2% | -$11.9K | 0.46% | 27 |
|
|
2024
Q4 | $638K | Sell |
3,588
-14
| -0.4% | -$2.49K | 0.38% | 37 |
|
|
2024
Q3 | $711K | Sell |
3,602
-13
| -0.4% | -$2.57K | 0.42% | 36 |
|
|
2024
Q2 | $620K | Buy |
3,615
+38
| +1% | +$6.52K | 0.39% | 39 |
|
|
2024
Q1 | $651K | Sell |
3,577
-390
| -10% | -$71K | 0.41% | 30 |
|
|
2023
Q4 | $615K | Sell |
3,967
-87
| -2% | -$13.5K | 0.41% | 39 |
|
|
2023
Q3 | $604K | Sell |
4,054
-15
| -0.4% | -$2.24K | 0.45% | 29 |
|
|
2023
Q2 | $548K | Sell |
4,069
-20
| -0.5% | -$2.7K | 0.39% | 42 |
|
|
2023
Q1 | $652K | Sell |
4,089
-1,008
| -20% | -$161K | 0.48% | 33 |
|
|
2022
Q4 | $824K | Sell |
5,097
-197
| -4% | -$31.8K | 0.66% | 23 |
|
|
2022
Q3 | $711K | Sell |
5,294
-74
| -1% | -$9.94K | 0.61% | 21 |
|
|
2022
Q2 | $822K | Hold |
5,368
| – | – | 0.66% | 17 |
|
|
2022
Q1 | $870K | Sell |
5,368
-59
| -1% | -$9.56K | 0.6% | 20 |
|
|
2021
Q4 | $735K | Hold |
5,427
| – | – | 0.5% | 27 |
|
|
2021
Q3 | $585K | Hold |
5,427
| – | – | 0.44% | 35 |
|
|
2021
Q2 | $611K | Hold |
5,427
| – | – | 0.45% | 32 |
|
|
2021
Q1 | $587K | Sell |
5,427
-1,727
| -24% | -$187K | 0.47% | 34 |
|
|
2020
Q4 | $767K | Sell |
7,154
-358
| -5% | -$38.4K | 0.68% | 13 |
|
|
2020
Q3 | $658K | Sell |
7,512
-185
| -2% | -$16.2K | 0.69% | 12 |
|
|
2020
Q2 | $756K | Sell |
7,697
-143
| -2% | -$14K | 0.83% | 11 |
|
|
2020
Q1 | $597K | Sell |
7,840
-68
| -0.9% | -$5.18K | 0.76% | 11 |
|
|
2019
Q4 | $700K | Buy |
+7,908
| New | +$700K | 0.63% | 17 |
|